Production (Stage)
Citius Oncology, Inc.
CTOR
$1.44
-$0.03-2.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.00 | 100.00 | 100.00 | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 15.34M | 14.38M | 8.27M | -- | -- |
| Prepaid Expenses | 2.70M | 2.70M | 2.70M | 10.01M | 8.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.04M | 17.08M | 10.97M | 10.01M | 8.91M |
|
|
|||||
| Total Current Assets | 18.04M | 17.08M | 10.97M | 10.01M | 8.91M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 73.40M | 73.40M | 73.40M | 40.00M | 40.00M |
| Total Assets | 91.44M | 90.48M | 84.37M | 50.01M | 48.91M |
|
|
|||||
| Total Accounts Payable | 7.68M | 5.87M | 3.71M | -- | 503.90K |
| Total Accrued Expenses | 13.66M | 9.12M | 588.80K | 31.39M | 27.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 28.40M | 28.40M | 28.40M | -- | -- |
| Total Other Current Liabilities | 28.40M | 28.40M | 28.40M | -- | -- |
| Total Current Liabilities | 49.74M | 43.40M | 32.70M | 31.39M | 27.62M |
|
|
|||||
| Total Current Liabilities | 49.74M | 43.40M | 32.70M | 31.39M | 27.62M |
| Long-Term Debt | 3.80M | 3.80M | 3.80M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.26M | 1.99M | 1.73M | 1.58M | 1.44M |
| Total Liabilities | 55.80M | 49.19M | 38.23M | 32.98M | 29.06M |
|
|
|||||
| Common Stock & APIC | 89.32M | 87.23M | 85.42M | 49.50M | 47.54M |
| Retained Earnings | -53.67M | -45.94M | -39.28M | -32.47M | -27.69M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 35.64M | 41.29M | 46.14M | 17.03M | 19.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.64M | 41.29M | 46.14M | 17.03M | 19.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.64M | 41.29M | 46.14M | 17.03M | 19.85M |
|
|
|||||